Todd M. Zimmerman

Initial genome sequencing and analysis of multiple myeloma

Michael A. Chapman, Michael S. Lawrence, Jonathan J. Keats et al. · Nature · 2011 · 1.4K citations · Full text

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

Jens G. Lohr, Petar Stojanov, Scott L. Carter et al. · Cancer Cell · 2014 · 988 citations · Full text

Hematological Malignancy, Disease Heterogeneity, Widespread Genetic Heterogeneity +7

Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma

Andrzej Jakubowiak, Don M. Benson, William Bensinger et al. · Journal of Clinical Oncology · 2012 · 202 citations · Full text

Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma

Shaji Kumar, William Bensinger, Todd M. Zimmerman et al. · Blood · 2014 · 192 citations · Full text

Allogeneic Stem-Cell Transplantation of Renal Cell Cancer After Nonmyeloablative Chemotherapy: Feasibility, Engraftment, and Clinical Results

Brian I. Rini, Todd M. Zimmerman, Walter M. Stadler et al. · Journal of Clinical Oncology · 2002 · 174 citations